JPH0436215A - Cosmetic having antiinflammatory property - Google Patents
Cosmetic having antiinflammatory propertyInfo
- Publication number
- JPH0436215A JPH0436215A JP2139061A JP13906190A JPH0436215A JP H0436215 A JPH0436215 A JP H0436215A JP 2139061 A JP2139061 A JP 2139061A JP 13906190 A JP13906190 A JP 13906190A JP H0436215 A JPH0436215 A JP H0436215A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- cosmetic
- salts
- amount
- ingredients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 24
- 230000003110 anti-inflammatory effect Effects 0.000 title claims abstract description 16
- 235000009814 Luffa aegyptiaca Nutrition 0.000 claims abstract description 24
- 150000003839 salts Chemical class 0.000 claims abstract description 17
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 claims abstract description 12
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims abstract description 12
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 8
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 8
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229960002684 aminocaproic acid Drugs 0.000 claims abstract description 7
- 229960004949 glycyrrhizic acid Drugs 0.000 claims abstract description 7
- 235000019410 glycyrrhizin Nutrition 0.000 claims abstract description 7
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 claims abstract description 6
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960003720 enoxolone Drugs 0.000 claims abstract description 6
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims abstract description 6
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000001685 glycyrrhizic acid Substances 0.000 claims abstract description 6
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960004889 salicylic acid Drugs 0.000 claims abstract description 6
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims abstract description 5
- 229960000401 tranexamic acid Drugs 0.000 claims abstract description 5
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 4
- 229960000458 allantoin Drugs 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 244000280244 Luffa acutangula Species 0.000 claims description 22
- -1 bizabolol Chemical compound 0.000 claims description 5
- 239000004615 ingredient Substances 0.000 abstract description 14
- 238000002156 mixing Methods 0.000 abstract description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 abstract 3
- 244000302544 Luffa aegyptiaca Species 0.000 abstract 2
- 230000002688 persistence Effects 0.000 abstract 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 abstract 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 abstract 1
- 241000219122 Cucurbita Species 0.000 abstract 1
- 235000009852 Cucurbita pepo Nutrition 0.000 abstract 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 abstract 1
- 229940036350 bisabolol Drugs 0.000 abstract 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 239000003205 fragrance Substances 0.000 description 8
- 239000008213 purified water Substances 0.000 description 7
- 206010015150 Erythema Diseases 0.000 description 6
- 231100000321 erythema Toxicity 0.000 description 6
- 229940121363 anti-inflammatory agent Drugs 0.000 description 4
- 239000002260 anti-inflammatory agent Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000005923 long-lasting effect Effects 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- CDVMRBKZDAJYGH-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;propane-1,2-diol Chemical compound CC(O)CO.OCCN(CCO)CCO CDVMRBKZDAJYGH-UHFFFAOYSA-N 0.000 description 2
- 241000219104 Cucurbitaceae Species 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000219138 Luffa Species 0.000 description 2
- 235000003956 Luffa Nutrition 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000010639 cypress oil Substances 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- KMYYNYQICOFADI-UHFFFAOYSA-N CCO.CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC Chemical compound CCO.CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC KMYYNYQICOFADI-UHFFFAOYSA-N 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 244000086363 Pterocarpus indicus Species 0.000 description 1
- 235000009984 Pterocarpus indicus Nutrition 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- DHCJUOOZDMXKGF-UHFFFAOYSA-L [Na+].[Na+].OC(=O)CC(O)(CC([O-])=O)C(O)=O.OC(=O)CC(O)(CC([O-])=O)C(O)=O Chemical compound [Na+].[Na+].OC(=O)CC(O)(CC([O-])=O)C(O)=O.OC(=O)CC(O)(CC([O-])=O)C(O)=O DHCJUOOZDMXKGF-UHFFFAOYSA-L 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000341 effect on erythema Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- 229960002350 guaiazulen Drugs 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Natural products OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- UQDVHJGNIFVBLG-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O UQDVHJGNIFVBLG-UHFFFAOYSA-N 0.000 description 1
- NKBWPOSQERPBFI-UHFFFAOYSA-N octadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC NKBWPOSQERPBFI-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000010292 orthophenyl phenol Nutrition 0.000 description 1
- 239000004306 orthophenyl phenol Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229950002760 sodium gualenate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- GEYJUFBPCGDENK-UHFFFAOYSA-M sodium;3,8-dimethyl-5-propan-2-ylazulene-1-sulfonate Chemical compound [Na+].CC(C)C1=CC=C(C)C2=C(S([O-])(=O)=O)C=C(C)C2=C1 GEYJUFBPCGDENK-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は消炎効果が高く、しかもその効果の持続性に優
れた化粧料に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a cosmetic that has a high anti-inflammatory effect and has an excellent long-lasting effect.
[従来の技術および課題]
従来から日焼は後の皮膚の消炎剤としては、アラントイ
ン、アロエエキス、アロエ末、イクタモール、グアイア
ズレン、グアイアズレンスルホン酸ナトリウム、グリチ
ルリチン酸などが知られている。例えば、特公昭53−
46892号公報には、ウリ科植物抽出物を配合した化
粧料が、皮膚に対する炎症効果を有すると記載されてい
る。また、特開昭63−179819号公報には、ヘチ
マサポニノが皮膚、粘膜の荒れ・たたれを防ぎ、創傷や
皮膚の損傷等に対しても治療効果があると記載されてい
る。しかしながら、これら何れの薬剤も一時的な消炎効
果は有するものの持続性に乏しく、充分な消炎効果は得
られなかった。[Prior Art and Problems] Conventionally, allantoin, aloe extract, aloe powder, ictamol, guaiazulene, sodium guaiazulene sulfonate, glycyrrhizinic acid, and the like have been known as anti-inflammatory agents for the skin after sunburn. For example,
Publication No. 46892 describes that a cosmetic containing a Cucurbitaceae plant extract has an inflammatory effect on the skin. Furthermore, Japanese Patent Application Laid-open No. 179819/1983 states that loofah saponino prevents roughness and sagging of the skin and mucous membranes, and has a therapeutic effect on wounds and skin damage. However, although all of these drugs have a temporary anti-inflammatory effect, they have poor sustainability, and a sufficient anti-inflammatory effect cannot be obtained.
本発明の目的は、皮膚の消炎作用に優れ、かつその持続
性の高い化粧料を提供することにある。An object of the present invention is to provide a cosmetic that has excellent anti-inflammatory effects on the skin and has a long-lasting effect.
[課題を解決するための手段]
本発明者らは、かかる観点から優れた消炎作用を有する
化粧料を得るべく、鋭意検討を重ねた結果、ヘチマ水に
ε−アミノカプロン酸、グリチルリチン酸なとの特定成
分を加えることにより、紫外線を一定量以上照射した場
合に生しる皮膚の紅斑を減じる作用が強化されることを
知り、本発明を完成するに至った。[Means for Solving the Problems] From this point of view, the present inventors have made extensive studies in order to obtain cosmetics with excellent anti-inflammatory effects, and have found that loofah water contains ε-aminocaproic acid and glycyrrhizic acid. The present invention was completed based on the knowledge that adding a specific component enhances the effect of reducing the erythema that appears on the skin when exposed to a certain amount of ultraviolet rays.
すなわち、本発明はヘチマ水と、ε−アミノカプロン酸
、グリチルリチン酸およびその塩、グリチルレチン酸お
よびその塩、アランドイツ、サリチル酸およびその塩、
ピザホロール、並びにトラネキサム酸より選ばれた少な
くとも1種の消炎剤成分とを配合した化粧料を提供する
ものである。That is, the present invention provides loofah water, ε-aminocaproic acid, glycyrrhizic acid and its salts, glycyrrhetinic acid and its salts, Alandeutschland, salicylic acid and its salts,
The present invention provides a cosmetic containing pizzaphorol and at least one anti-inflammatory agent selected from tranexamic acid.
本発明で使用する「ヘチマ」はウリ科
(Cucurbitaceae)のLuffa cyl
indrica Roemである。本発明で使用するヘ
チマ水は、ヘチマの果実または茎から浸出する液汁であ
り、公知の方法により採取することかできる。"Luffa" used in the present invention is Luffa cyl of Cucurbitaceae.
indrica Roem. The loofah water used in the present invention is sap exuded from the fruit or stem of loofah, and can be collected by a known method.
採取したヘチマ水は、そのまま放置すると腐敗、菌の繁
殖等が生ずる。このため採取したヘチマ水にエタノール
、パラオキシ安息香酸エステルまたはその塩、安息香酸
またはその塩、サリチル酸またはその塩、ソルビン酸ま
たはその塩、デヒドロ酢酸またはその塩、イソプロピル
メチルフェノール、オルトフェニルフェノール、クレゾ
ール、フェノキンエタノールなとの防腐剤を適宜添加す
ることが望ましい。If the collected loofah water is left as it is, it will rot and the growth of bacteria will occur. For this purpose, the collected loofah water contains ethanol, paraoxybenzoic acid ester or its salt, benzoic acid or its salt, salicylic acid or its salt, sorbic acid or its salt, dehydroacetic acid or its salt, isopropylmethylphenol, orthophenylphenol, cresol, It is desirable to add a preservative such as phenoquine ethanol as appropriate.
また、ヘチマ水の配合量は、化粧料全量中の3〜99重
量%、好ましくは、5〜95重量%、さらに好ましくは
10〜90重量%である。The amount of loofah water blended is 3 to 99% by weight, preferably 5 to 95% by weight, and more preferably 10 to 90% by weight based on the total amount of the cosmetic.
ヘチマ水の配合量が3%未満であると消炎効果の発現が
不十分てあり、一方99%を超えるとヘチマ水の保存安
定性か低下し好ましくない。If the blending amount of loofah water is less than 3%, the anti-inflammatory effect will not be sufficiently expressed, while if it exceeds 99%, the storage stability of loofah water will decrease, which is not preferable.
本発明化粧料においてヘチマ水と共に用いられる成分と
しては、ε−アミノカプロン酸、グリチルリチン酸およ
びそのノカリウム塩、などの塩グリチルレチン酸および
そのエステルおよび塩アラントイン、サリチル酸および
その塩、ヒザホロール、並びにトラネキサム酸などが挙
げられる。Ingredients used with loofah water in the cosmetics of the present invention include salts of glycyrrhetinic acid and its esters such as ε-aminocaproic acid, glycyrrhizic acid and its potassium salt, salts of allantoin, salicylic acid and its salts, hizafolol, and tranexamic acid. Can be mentioned.
これらは単独でまた併用して配合されてよい。これら成
分の配合量は、化粧料全量に対して0005〜5重量%
、好ましくは0.05〜2重量%である。These may be used alone or in combination. The blending amount of these ingredients is 0005 to 5% by weight based on the total amount of cosmetics.
, preferably 0.05 to 2% by weight.
かかる成分の配合量がこれより少ないと皮膚の炎症に対
する充分な消炎効果が発現せず、上限を越えると好まし
い使用感の化粧料が得られない。If the amount of such ingredients is less than this, a sufficient anti-inflammatory effect against skin inflammation will not be exhibited, and if it exceeds the upper limit, a cosmetic with a preferable feeling of use will not be obtained.
つぎに本発明化粧料の消炎性について第1表に示す組成
の化粧料を用いて試験した。試験No、1〜9の溶液を
用いて大背部の紫外線照射に対する紅斑の抑制試験を行
った。試験;よ成人男子10名を用いて各試料約0 、
1 mQを、波長300〜380nmの紫外線発生装置
を用いて5分間、距離50cmより照射した後、直ちに
塗布し、6時間後の紅斑の程度を比較することにより行
った。刺激の程度は以下のように数値化を行った。Next, the anti-inflammatory properties of the cosmetics of the present invention were tested using cosmetics having the compositions shown in Table 1. Using the solutions of Test Nos. 1 to 9, an erythema suppression test against ultraviolet irradiation of the large back was conducted. Test: Approximately 0% of each sample was used using 10 adult males.
After irradiating 1 mQ for 5 minutes from a distance of 50 cm using an ultraviolet light generator with a wavelength of 300 to 380 nm, the test was applied immediately, and the degree of erythema was compared after 6 hours. The degree of stimulation was quantified as follows.
0 非照射部と同し わずかに紅斑 23より程度の弱い紅斑 3・明瞭な紅斑 4 未塗布部よりやや東い紅斑 5 未塗布部と同じ 結果を第1表に合わせ示す。0 Same as non-irradiated area slightly erythematous Erythema less severe than 23 3.Clear erythema 4. Erythema slightly easter than the unapplied area 5 Same as uncoated area The results are also shown in Table 1.
上記の結果より、検討に供した消炎剤を単独で用いた場
合およびへちま水を単独で用いた場合と比較して、両者
を併用した場合は明確に紅斑の抑制作用が増強している
。From the above results, compared to when the anti-inflammatory agent used in the study was used alone and when loofah water was used alone, when both were used in combination, the suppressive effect on erythema was clearly enhanced.
これらの結果から前記の消炎側単独では充分な効果が得
られなかったが、ヘチマ水と共に用いると顕著な消炎効
果が発現することが判明した。さらにヘチマ水を添加す
ることにより、刺激のない化粧料が得られる。From these results, it was found that although sufficient anti-inflammatory effects were not obtained when the anti-inflammatory agent was used alone, a significant anti-inflammatory effect was obtained when used together with loofah water. Furthermore, by adding loofah water, a non-irritating cosmetic can be obtained.
本発明の消炎性を有する化粧料は、公知の方法によりク
リーム、乳液、化粧水、アフターシェイブローメタン、
ヘアトニック、バック、ファンデーション、エツセンス
など様々な形態の頭部用を含む皮膚化粧料に調製される
。The anti-inflammatory cosmetics of the present invention can be prepared by known methods such as creams, milky lotions, lotions, aftershave brow methane,
It is prepared into various types of skin cosmetics, including hair tonics, makeup products, foundations, and essences for the head.
さらに、本発明の化粧料には、その種類に応じ性能を損
なわない範囲において、適宜公知の成分を配合すること
ができる。すなわち、本発明の化粧料には上記必須成分
の他に、通常化粧料に用いられ配合される成分、例えば
、油分、紫外線吸収剤、酸化防止剤、界面活性剤、防腐
剤、香料、水、アルコール、増粘剤、色素等を必要に応
じて適宜配合することができる。Furthermore, the cosmetic composition of the present invention may contain any known components as appropriate, depending on the type thereof, within a range that does not impair performance. That is, in addition to the above-mentioned essential ingredients, the cosmetic of the present invention contains ingredients normally used and blended in cosmetics, such as oil, ultraviolet absorbers, antioxidants, surfactants, preservatives, fragrances, water, Alcohol, thickener, pigment, etc. can be added as appropriate.
[実施例コ
つぎに本発明を実施例にもとづきさらに具体的に説明す
る。実施例において配合量は重量%てあられす。[Example] Next, the present invention will be explained in more detail based on an example. In the examples, the amounts are expressed in weight%.
実施例1(クリーム)
成 分 配合量ステアリン
酸 2.0セタノール
5.0ミツロウ
2.0流動パラフイン
5・0トリオクタン酸グリセ
リル 50ポリオキシエチレン(20
E、O,)
セチルエーテル 20自己乳化型
モノステアリン酸グリセリン 30パラオキン安息香
酸メチル OIパラオキノ安息香酸エチ
ル 0.3香料
0.2プロピレングリコール
50ヘチマ水
グリチルリチン酸ノカリウム
水酸化カリウム
ε−アミノカプロン酸
精製水
計
残部
実施例2(乳液)
成 分
ステアリン酸
セタノール
ワセリン
ミツロウ
スクワラン
グリチルレチン酸ステアリル
モノステアリン酸ポリオキンエチレン
ソルビタン(20E、O,)
トリエタノールアミン
プロピレングリコール
香料
配合量
1.5
0.8
ヘチマ水
バラオキノ安萄香酸メチル
エタノール
精製水
計
実施例3(化粧水)
成 分
ポリオキノエヂレノ硬化ヒマノ油
エタノール
香料
ヘチマ水
グリチルリチン酸ノカリウム
d1〜ピロリドンカルボン酸ナトリウムクエン酸ナトリ
ウム
クエン酸
精製水
計
残部
配合量
残部
!00
実施例4(アフターノエイブローノヨレ)成 分
ポリオキシエチレン硬化ヒマノ油
(60E、O,)
エタノール
香料
ヘチマ水
アラントイン
サリチル酸
クエン酸ナトリウム
精製水
計
実施例5(ヘアトニック)
成 分
ポリオキシエチレン(20E、O,)
セチルエーテル
エタノール
香料
塩酸ピリドキノン
サリチル酸
配合量
0.7
0.3
30.0
0.2
0.2
0.1
残部
配合量
1.0
55.0
0.7
I
O,1
ヘチマ水
dl−ピロリドンカルボン酸ナトリウムニコチン酸ベン
ジル
グリチルリチン酸ジカリウム
精製水
計
実施例6(ファンデーション)
成 分
スクワラン
流動パラフィン
固形パラフィン
オリブ油
ステアリン酸
親油型モノステアリン酸グリセリン
モノステアリン酸ポリオキンエチレン
ソルビタン(20E、O,)
トリエタノールアミン
プロピレングリコール
α−ビザポロール
0.005
0.3
残部
配合量
4.0
2.0
2.0
2.5
1.5
5.0
パラオキシ安息香酸メチル
香料
酸化チタン
黒酸化鉄
黄酸化鉄
ベンガラ
ヘチマ水
カルボキンビニルポリマー
精製水
計
0.2
0.2
7.5
0.05
残部
ポリオキノエチレン(60E
硬化ヒマノ油
香料
トラネキサム酸
精製水
計
残部
+00
[発明の効果二
本発明の化粧料は、皮膚の消炎作用に優れ、かつその効
果の持続性か高い。Example 1 (cream) Ingredients Amount Stearic acid 2.0 Cetanol
5.0 beeswax
2.0 liquid paraffin
5.0 glyceryl trioctanoate 50 polyoxyethylene (20
E, O,) Cetyl ether 20 Self-emulsifying glycerin monostearate 30 Methyl paraoquinobenzoate OI Ethyl paraoquinobenzoate 0.3 Fragrance
0.2 propylene glycol
50 Loofah water Potassium glycyrrhetinic acid Potassium hydroxide ε-Aminocaproic acid Purified water meter Remaining Example 2 (Emulsion) Ingredients Setanol stearate Vaseline Beeswax squalane Glycyrrhetinic acid stearyl Monostearate Polyoquine Ethylene sorbitan (20E, O,) Triethanolamine Propylene glycol fragrance compounding amount 1.5 0.8 Loofah water Rosewood methyl beanzoate ethanol Purified water meter Example 3 (lotion) Ingredients Polyochinoedyleno hydrogenated cypress oil Ethanol Fragrance Loofah water Glycyrrhizinate monopotassium d1 ~ Pyrrolidone carvone Acid Sodium Citrate Sodium Citric Acid Purified Water Meter Remaining Blend Amount Remaining! 00 Example 4 (Afternoe Brow Noyore) Ingredients Polyoxyethylene Hydrogenated Himano Oil (60E, O,) Ethanol Fragrance Loofah Water Allantoinsalicylic Acid Sodium Citrate Purified Water Meter Example 5 (Hair Tonic) Ingredients Polyoxyethylene (20E , O,) Cetyl ether ethanol fragrance hydrochloride pyridoquinone salicylic acid Blending amount 0.7 0.3 30.0 0.2 0.2 0.1 Remaining blending amount 1.0 55.0 0.7 I O,1 Loofah Water dl-Sodium pyrrolidonecarboxylate Benzyl nicotinic acid Dipotassium glycyrrhizate Purified water meter Example 6 (foundation) Ingredients Squalane Liquid paraffin Solid paraffin Olive oil Stearic acid Lipophilic monostearate Glycerin Monostearate Polyoquine Ethylene sorbitan (20E, O,) Triethanolamine propylene glycol α-visaporol 0.005 0.3 Remaining amount 4.0 2.0 2.0 2.5 1.5 5.0 Methyl paraoxybenzoate Fragrance Titanium oxide Black Iron oxide Yellow oxide Iron loofah water Carboquine vinyl polymer Purified water Total 0.2 0.2 7.5 0.05 Balance polyochinoethylene (60E Hardened cypress oil fragrance Tranexamic acid Purified water Total balance +00 [Effects of the invention 2 Cosmetics of the present invention has excellent anti-inflammatory effects on the skin and its effects are long-lasting.
実施例7(エツセンス) 成 分 ヘチマ水 クエン酸ナトリウム ヒドロキシエチルセルロースナトリウムキサンタンガム グリセリン エタノール パラオキシ安息香酸メチルExample 7 (Essence) Component loofah water sodium citrate Hydroxyethyl cellulose sodium xanthan gum glycerin ethanol Methyl paraoxybenzoate
Claims (1)
チン酸およびその塩、グリチルレチン酸およびその塩、
アラントイン、サリチル酸およびその塩、ビザボロール
、並びにトラネキサム酸より選ばれた少なくとも1種の
成分とを配合した消炎性を有する化粧料。(1) Loofah water: ε-aminocaproic acid, glycyrrhizic acid and its salts, glycyrrhetinic acid and its salts,
A cosmetic having anti-inflammatory properties, containing at least one component selected from allantoin, salicylic acid and its salts, bizabolol, and tranexamic acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2139061A JPH0725660B2 (en) | 1990-05-29 | 1990-05-29 | Cosmetics with anti-inflammatory properties against sunburn |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2139061A JPH0725660B2 (en) | 1990-05-29 | 1990-05-29 | Cosmetics with anti-inflammatory properties against sunburn |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0436215A true JPH0436215A (en) | 1992-02-06 |
JPH0725660B2 JPH0725660B2 (en) | 1995-03-22 |
Family
ID=15236582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2139061A Expired - Fee Related JPH0725660B2 (en) | 1990-05-29 | 1990-05-29 | Cosmetics with anti-inflammatory properties against sunburn |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0725660B2 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993025209A1 (en) * | 1992-06-18 | 1993-12-23 | Fabulon Rg Kozmetikai Kft. | Compositions for the treatment and prophylaxis of inflammations and dermatoses induced by viruses and process for the preparation thereof |
JPH06135821A (en) * | 1992-10-30 | 1994-05-17 | Kanebo Ltd | Hair tonic |
JPH0761938A (en) * | 1993-08-25 | 1995-03-07 | Shimizu Kagaku Kk | Medicinal composition for external use consists of hydrophilic polysaccharides |
FR2826579A1 (en) * | 2001-06-29 | 2003-01-03 | Pharmascience Lab | COSMETIC COMPOSITION CONTAINING AT LEAST ONE OIL EXTRACTED FROM CUCURBITACEOUS SEEDS, ITS COSMETIC, THERAPEUTIC AND FOOD USE |
FR2828811A1 (en) * | 2001-08-27 | 2003-02-28 | Sederma Sa | USE OF LUFFA CYLINDRICA OIL IN RELIPIDANT COSMETIC AND DERMOPHARMACEUTICAL COMPOSITIONS |
EP1382342A1 (en) * | 2002-07-18 | 2004-01-21 | Cognis Iberia, S.L. | Use of compositiosn comprising glycyrrhetinic acid and salicylic acid for acne treatment |
JP2005526822A (en) * | 2002-04-09 | 2005-09-08 | シンクレア ファーマシューティカルズ リミテッド | Topical pharmaceutical composition comprising proanthocyanidins for treating dermatitis |
JP2012201649A (en) * | 2011-03-28 | 2012-10-22 | Mikimoto Pharmaceut Co Ltd | Whitening agent and skin care preparation blended therewith |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5041655A (en) * | 1973-08-16 | 1975-04-16 | ||
JPS56122308A (en) * | 1980-01-31 | 1981-09-25 | Colgate Palmolive Co | Oral cavity composition |
JPS58213707A (en) * | 1982-06-08 | 1983-12-12 | Lion Corp | Composition for oral cavity |
JPS591406A (en) * | 1982-06-28 | 1984-01-06 | Fukue Ito | Preparation of skin lotion |
JPS5913716A (en) * | 1982-07-16 | 1984-01-24 | Lion Corp | Composition for external use |
JPS61194008A (en) * | 1985-02-25 | 1986-08-28 | Shiseido Co Ltd | Cosmetic |
JPS61263910A (en) * | 1985-05-20 | 1986-11-21 | Shiseido Co Ltd | Hair cosmetic |
JPS61289010A (en) * | 1985-06-15 | 1986-12-19 | Nonogawa Shoji:Kk | Cosmetic |
JPS61291515A (en) * | 1985-06-19 | 1986-12-22 | Shiseido Co Ltd | Cosmetic |
JPS62234013A (en) * | 1986-04-02 | 1987-10-14 | Osaka Yakuhin Kenkyusho:Kk | Bathing agent |
JPS63179819A (en) * | 1987-01-21 | 1988-07-23 | Shoei Kagaku Kogyo Kk | Skin external preparation containing luffe cylindrica essence for peripheral part of anus |
JPH054574A (en) * | 1990-10-16 | 1993-01-14 | Aisin Seiki Co Ltd | Antiskid control device |
-
1990
- 1990-05-29 JP JP2139061A patent/JPH0725660B2/en not_active Expired - Fee Related
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5041655A (en) * | 1973-08-16 | 1975-04-16 | ||
JPS56122308A (en) * | 1980-01-31 | 1981-09-25 | Colgate Palmolive Co | Oral cavity composition |
JPS58213707A (en) * | 1982-06-08 | 1983-12-12 | Lion Corp | Composition for oral cavity |
JPS591406A (en) * | 1982-06-28 | 1984-01-06 | Fukue Ito | Preparation of skin lotion |
JPS5913716A (en) * | 1982-07-16 | 1984-01-24 | Lion Corp | Composition for external use |
JPS61194008A (en) * | 1985-02-25 | 1986-08-28 | Shiseido Co Ltd | Cosmetic |
JPS61263910A (en) * | 1985-05-20 | 1986-11-21 | Shiseido Co Ltd | Hair cosmetic |
JPS61289010A (en) * | 1985-06-15 | 1986-12-19 | Nonogawa Shoji:Kk | Cosmetic |
JPS61291515A (en) * | 1985-06-19 | 1986-12-22 | Shiseido Co Ltd | Cosmetic |
JPS62234013A (en) * | 1986-04-02 | 1987-10-14 | Osaka Yakuhin Kenkyusho:Kk | Bathing agent |
JPS63179819A (en) * | 1987-01-21 | 1988-07-23 | Shoei Kagaku Kogyo Kk | Skin external preparation containing luffe cylindrica essence for peripheral part of anus |
JPH054574A (en) * | 1990-10-16 | 1993-01-14 | Aisin Seiki Co Ltd | Antiskid control device |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993025209A1 (en) * | 1992-06-18 | 1993-12-23 | Fabulon Rg Kozmetikai Kft. | Compositions for the treatment and prophylaxis of inflammations and dermatoses induced by viruses and process for the preparation thereof |
JPH06135821A (en) * | 1992-10-30 | 1994-05-17 | Kanebo Ltd | Hair tonic |
JPH0761938A (en) * | 1993-08-25 | 1995-03-07 | Shimizu Kagaku Kk | Medicinal composition for external use consists of hydrophilic polysaccharides |
JP2527132B2 (en) * | 1993-08-25 | 1996-08-21 | 清水化学株式会社 | Topical drug composition comprising hydrophilic polysaccharide |
WO2003002088A3 (en) * | 2001-06-29 | 2003-04-17 | Pharmascience Lab | Use of an oil of the gourd family for inhibiting 5$g(a)-reductase activity |
FR2826579A1 (en) * | 2001-06-29 | 2003-01-03 | Pharmascience Lab | COSMETIC COMPOSITION CONTAINING AT LEAST ONE OIL EXTRACTED FROM CUCURBITACEOUS SEEDS, ITS COSMETIC, THERAPEUTIC AND FOOD USE |
US7238377B2 (en) | 2001-06-29 | 2007-07-03 | Laboratoires Expanscience | Use of an oil of the gourd family for inhibiting 5 alpha-reductase activity |
FR2828811A1 (en) * | 2001-08-27 | 2003-02-28 | Sederma Sa | USE OF LUFFA CYLINDRICA OIL IN RELIPIDANT COSMETIC AND DERMOPHARMACEUTICAL COMPOSITIONS |
WO2003017966A3 (en) * | 2001-08-27 | 2003-11-06 | Sederma Sa | Use of luffa cylindrica oil in cosmetic and dermopharmaceutical compositions |
JP2005526822A (en) * | 2002-04-09 | 2005-09-08 | シンクレア ファーマシューティカルズ リミテッド | Topical pharmaceutical composition comprising proanthocyanidins for treating dermatitis |
JP4861606B2 (en) * | 2002-04-09 | 2012-01-25 | シンクレア ファーマシューティカルズ リミテッド | Topical pharmaceutical composition comprising proanthocyanidins for treating dermatitis |
EP1382342A1 (en) * | 2002-07-18 | 2004-01-21 | Cognis Iberia, S.L. | Use of compositiosn comprising glycyrrhetinic acid and salicylic acid for acne treatment |
WO2004009096A1 (en) * | 2002-07-18 | 2004-01-29 | Cognis Iberia, S.L. | Use of compositions comprising salicylic acid and glycyrrhetinic acid for the treatment of acne |
JP2012201649A (en) * | 2011-03-28 | 2012-10-22 | Mikimoto Pharmaceut Co Ltd | Whitening agent and skin care preparation blended therewith |
Also Published As
Publication number | Publication date |
---|---|
JPH0725660B2 (en) | 1995-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2482809B1 (en) | Compositions comprising an anti-inflammatory blend | |
EP2174648B1 (en) | Skin-care compositions and uses thereof | |
WO2010046291A2 (en) | Use of hydroxycinnamic acids and derivatives thereof and/or of plant extracts for treating body odor | |
DE60218922T2 (en) | Method for increasing the tolerance threshold for sensitive skin | |
DE69500016T2 (en) | Cosmetic composition containing an associate of superoxide dismutase and porphyrins | |
JP2003533462A (en) | Use of ergothioneine and / or a derivative thereof as an antifouling agent | |
JPH11116492A (en) | Melanin formation inhibitor and its use | |
EP2322138A2 (en) | Antimicrobial composition | |
JPH0436215A (en) | Cosmetic having antiinflammatory property | |
CA2357961A1 (en) | Method for reduction of inflammation and erythema | |
JP2004175750A (en) | Dermopathy inhibitor and dermopathy improving agent, and skin care preparation for external use containing them | |
JPS61215318A (en) | External agent for skin | |
JP3460904B2 (en) | External preparation for skin | |
JPS63280006A (en) | Agent for suppressing irritant feeling of skin and cosmetic containing said agent | |
JP2881333B2 (en) | Whitening cosmetics | |
JP2676049B2 (en) | Skin cosmetics | |
JPH11139951A (en) | Cosmetic | |
JPH09291012A (en) | Antiphlogistic skin cosmetic | |
JPH10279427A (en) | Moisture-retaining cosmetic material composition | |
JPH0429919A (en) | Moisture-retaining cosmetic | |
JP2002145754A (en) | Skin cosmetic | |
JPH072640A (en) | External preparation for protecting ultraviolet disorder | |
JPS63215611A (en) | Cosmetic | |
JP2003533461A (en) | Antifouling compositions based on anthocyans | |
JP2000178118A (en) | Humectant, skin cosmetic and bathing agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080322 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090322 Year of fee payment: 14 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090322 Year of fee payment: 14 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100322 Year of fee payment: 15 |
|
LAPS | Cancellation because of no payment of annual fees |